Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Asara raises $25m to accelerate exploration at Kada July 28, 2025 Next Post Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs July 28, 2025 Related Posts Earthwise Advertising & Investor Awareness Campaign August 30, 2025 Charbone Hydrogen Announces Q2 2025 Financial Results August 30, 2025 Charbone Hydrogene annonce les resultats financiers T2 2025 August 30, 2025